Re­al-time re­views for cell and gene ther­a­pies? Pfiz­er to FDA: Yes, please

The FDA’s On­col­o­gy Cen­ter of Ex­cel­lence has a pro­gram, known as Re­al-Time On­col­o­gy Re­view (RTOR), that speeds up can­cer drug ap­provals, some­times by months, but …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER